Go to Client Portal
NAMSA

NAMSA IS THE WORLD’S LEADING MEDTECH CRO OFFERING GLOBAL DEVELOPMENT SERVICES

Contact Us Today

DRIVEN BY ITS GLOBAL REGULATORY EXPERTISE AND IN-DEPTH THERAPEUTIC KNOWLEDGE

Contact Us Today

FROM CONCEPT TO POST-MARKET, DELIVERING SIGNIFICANT TIME SAVINGS VS. INDUSTRY AVERAGES

Contact Us Today

HELPING MEDICAL DEVICE SPONSORS IMPROVE HEALTHCARE SINCE 1967

Contact Us Today

Our Services

Driven by our global regulatory expertise and in-depth therapeutic knowledge, NAMSA is a medical CRO offering only the most proven solutions to move your medical device through the development lifecycle as efficiently and cost-effectively as possible.

As a medical contract research organization, we are dedicated to helping you achieve accelerated, successful development and commercialization outcomes. NAMSA’s offerings include medical device testing; regulatory, reimbursement and quality consulting; and clinical research services.

Learn More

Resources

Learn from the world’s leading medical CRO with complimentary access to our latest white papers, webinars, and other resources to learn proven strategies and best practices for successful medical device development and commercialization outcomes.

Browse All Resources

Blog

Always on the pulse of industry news, we interpret the latest regulatory guidelines and other medical device updates so you don’t have to. Learn from the world’s most trusted medical device CRO to stay up-to-date on recent news and what it means for your medical device development plans and commercial operations.

Access Now

FDA’s Regulation of AI/ML SaMD

Explore the differences in medical device software regulations between the EU's MDR and the US FDA, including SaMD, SiMD, and cybersecurity guidance.

Read More

Comparing US FDA vs EU MDR Medical Device Software Requirements

Explore the differences in medical device software regulations between the EU's MDR and the US FDA, including SaMD, SiMD, and cybersecurity guidance.

Read More

Bioburden Testing vs. Sterility Testing: What Is The Difference?

Bioburden testing quantifies living microorganisms on medical devices pre-sterilization, while sterility testing confirms their absence post-sterilization. Both are vital for patient safety and product efficacy.

Read More

Medical Device Reimbursement Payer Research: Key Areas of Payer Research

Understanding the intricate dynamics of payer preferences and decision-making criteria allows stakeholders in the healthcare landscape to align their offerings with payer requirements, fostering mutually beneficial relationships and ensuring the acceptance of innovative healthcare solutions.

Read More

Summary of Safety and Clinical Performance Best Practices

Navigate the complexities of SSCP development with expert insights on ensuring compliance, readability, and alignment with EU MDR Article 32 for medical devices.

Read More

HAVE QUESTIONS?

Let NAMSA’s medical device development experts guide you in the right direction.